After its synthesis, almost 90 % is retained into the cytoplasm (Meredith and Reed 1982, Hwang et al
These results help researchers understand how Epithalon works at the cell signaling level, especially in aging and long-term cell studies
Mehta P, McAuley DF, Brown M, Sanchez E, Tattersall RS, Manson JJ, et al
Despite these advancements, a significant challenge persists in the inability to directly target GSH
Note: Published safety data for TB-500 specifically is limitedmost evidence comes from Thymosin Beta-4 studies
The views expressed are those of the author(s) and not necessarily those of the NIHR or the Department of Health and Social Care